Research Topics
| Sten HolmangSummaryCountry: Sweden Publications
| Collaborators
|
Detail Information
Publications
Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-GuérinPatrik Andius
Department of Urology, Sahlgrenska University Hospital, , Sweden
Scand J Urol Nephrol 38:285-90. 2004..The accumulated incidence of patients with bladder CIS and a subsequent upper urinary tract tumour is rather high but it is questionable whether the prognosis will improve if routine follow-up urographies are performed...- Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancerSten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Scand J Urol Nephrol 40:479-84. 2006..To investigate the relationships between diagnostic and treatment delay and tumour stage and survival among patients with malignant tumours in the renal pelvis and ureter... - Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer RegistrySten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Scand J Urol Nephrol 42:12-7. 2008..To study the completeness and correctness of the Swedish Cancer Registry (SCR) for renal pelvic and ureteral carcinomas diagnosed in western Sweden... - Micropapillary carcinoma of the renal pelvis and ureterSten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
J Urol 175:463-6; discussion 466-7. 2006..MPC located in the upper urinary tract is rare with only 2 cases reported to date. We report clinical and histopathological data on 26 patients to increase the knowledge of this rare entity... - Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcomeSten Holmang
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
Cancer 101:741-7. 2004..Synchronous bilateral urothelial tumors of the upper urinary tract are very rare. The authors reported baseline and long-term follow-up data for all patients in western Sweden during a 28-year period... - Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcomeSten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
J Urol 175:69-72; discussion 72-3. 2006..Metachronous bilateral UUTTs are rare. The authors reported baseline and long-term followup data for all patients diagnosed in Western Sweden during a 28-year period... - Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification systemSten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Urology 66:274-8. 2005..Only a few bladder tumor studies have compared these systems... - Tumours of the ureter and renal pelvis treated with resection and renal autotransplantation: a study with up to 20 years of follow-upSten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, S 413 45 Sweden
BJU Int 95:1201-5. 2005..To report long-term follow-up data from patients treated with resection of urothelial neoplasms of the upper urinary tract combined with autotransplantation of the kidney... - Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcomeSten Holmang
Department of Urology, Sahlgrenska University Hospital Goteborg, Sweden
J Urol 178:51-6. 2007..Squamous cell carcinomas of the renal pelvis and ureter are rare. We report a large series of patients and compare it to patients with urothelial carcinoma... - Urinary diversion after cystectomy for bladder cancer: a population-based study in SwedenStaffan Jahnson
Department of Urology, University Hospital, Linkoping, Sweden
Scand J Urol Nephrol 44:69-75. 2010..To investigate the type of urinary diversion performed after cystectomy in patients with muscle-invasive bladder cancer in Sweden, using data from a population-based national register... - Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based surveyFredrik Liedberg
Department of Urology, Växjö County Hospital, Vaxjo, Sweden
Scand J Urol Nephrol 46:14-8. 2012..To evaluate outcome after radical cystectomy for primary bladder cancer in a large population-based material... - Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancerLennart Aström
Department of Oncology, University of Gothenburg, Gothenburg, Sweden
Radiother Oncol 74:157-61. 2005..If the alpha/beta ratio is low for PC, hypofractionation will be of advantage. A retrospective analysis of outcome in patients (pts) consecutively treated with combined HDR-BT and conformal external beam radiotherapy (ERT) was performed... - The cost of bladder tumour treatment and follow-upHans Hedelin
Department of Urology, Karnsjukhuset, Skovde, Sweden
Scand J Urol Nephrol 36:344-7. 2002..To evaluate the costs of bladder tumour treatment and follow-up... - Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasionPatrik Andius
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Urology 70:758-62. 2007..We studied the prognostic factors for progression and disease-specific survival in patients with Stage T1 bladder cancer to identify subgroups with different prognoses... - Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?Sten Holmang
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Eur Urol 61:503-7. 2012..It is not known how long follow-up cystoscopy in tumour-free bacillus Calmette-Guérin (BCG)-treated patients should continue... - A population-based study of patterns of care for muscle-invasive bladder cancer in SwedenStaffan Jahnson
Department of Urology, University Hospital, Linkoping, Sweden
Scand J Urol Nephrol 43:271-6. 2009..e. cystectomy or radiotherapy) in relation to patient, tumour and hospital characteristics... - Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre studyMartin C Schumacher
Department of Molecular Medicine and Surgery, Karolinska Institutet, Department of Urology, Stockholm, Sweden
Eur Urol 57:293-9. 2010..Most reports are from single centres with relatively few patients... - High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one centerBo Lennernas
Department of Oncology, Sahlgrenska University Hospital, Sweden
Strahlenther Onkol 178:537-41. 2002..To report the long-term follow-up of 50 patients with prostatic adenocarcinoma (PAC) treated by high-dose rate brachytherapy in combination with external beam radiotherapy... - Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progressionSten Holmang
Department of Urology, Sahlgrenska University Hospital, , Sweden
J Urol 167:1634-7. 2002..In our opinion followup should not be less intense in patients with high grade carcinoma (WHO 2-3), even in those with stage pTa disease... - A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrencesIngela Berrum-Svennung
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
J Urol 179:101-5; discussion 105-6. 2008..We studied whether a single instillation of epirubicin after transurethral bladder tumor resection would influence the interval to and size of the first recurrence... - Late bacille Calmette-Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatmentViveka Ströck
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
BJU Int 107:1592-7. 2011..To report a late bacille Calmette-Guérin (BCG) complication previously not described in the literature... - A randomized trial comparing 2 doses of polidocanol sclerotherapy for hydrocele or spermatoceleStaffan Jahnson
Department of Urology, Institution of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
J Urol 186:1319-23. 2011..We compared the efficacy and morbidity of 2 or 4 ml polidocanol sclerotherapy for hydrocele or spermatocele... - Costs of radical cystectomyIngela Berrum-Svennung
Department of Urology, Sahlgrenska University Hospital, , Sweden
Scand J Urol Nephrol 39:36-41. 2005..If the amount of bleeding can be influenced then substantial reductions in the total costs of cystectomy would seem possible...